Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
News|Articles|February 28, 2025
Black History Month in Review
Author(s)Megan McSweeney
Recap Psychiatric Times Black History Month coverage, including welcoming a new sports psychiatry section editor and a clinical conversation on using CBT to empower Black patients.
Advertisement
Advertisement
This month, Psychiatric Times celebrated Black History Month with discussions on using cognitive behavioral therapy to empower Black patients and welcoming Wilsa M.S. Charles Malveaux, MD, MA, FAPA, as the sports psychiatry section editor.
Related to this article
Medicare claims show pimavanserin in Parkinson psychosis nursing homes links to fewer falls and recurrent falls than quetiapine or other antipsychotics.
Learn how to prevent and spot tardive dyskinesia from antipsychotics, track key risk factors, and treat symptoms with VMAT2 inhibitors.
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
In this case exploration, a teen survives a gun injury yet denies self-harm, pushing clinicians to read beyond words and plan safety when suicide intent is unclear.
How tuning body signals with closed-loop sound and chill tech may ease dissociation and anhedonia, offering drug-free add-ons to therapy.
Two grief experts expose the hidden health, social, and economic toll of bereavement—and the policy gaps leaving millions of grieving Americans unsupported.
Learn how the inhibition constant and 5-HT2A binding explain LSD effects—and why potent atypical antipsychotics may rapidly end a bad trip.
Advertisement
Advertisement